chalazion incision and curettage: Definition, Uses, and Clinical Overview

Posted on February 27, 2026 | by dreye

chalazion incision and curettage Introduction (What it is)

chalazion incision and curettage is a minor eyelid procedure used to treat a chalazion.
A chalazion is a firm eyelid lump caused by blockage and inflammation of an oil gland.
The procedure opens the lesion and removes the thickened contents to help it resolve.
It is commonly performed by ophthalmologists, and sometimes by trained clinicians in eye-care settings.

Why chalazion incision and curettage used (Purpose / benefits)

The main purpose of chalazion incision and curettage is to reduce or remove a persistent eyelid lump (chalazion) when it has not improved with conservative measures or when it is causing meaningful symptoms.

A chalazion forms when a meibomian gland (an oil-producing gland in the eyelid) becomes blocked. The trapped oily material can trigger a localized inflammatory reaction, leading to a slowly enlarging, usually non-infectious nodule within the eyelid. While many chalazia gradually improve over time, some persist, recur, or become cosmetically or functionally significant.

Potential benefits of chalazion incision and curettage include:

Mechanical removal of the obstructed material that is sustaining inflammation
Faster reduction of the lump compared with continued observation in selected cases (timing varies by clinician and case)
Relief of pressure, tenderness, or irritation when the lesion is symptomatic
Improved eyelid contour and appearance when the lump is visible
Reduced corneal disturbance when a large chalazion presses on the eye surface and contributes to blurred vision from induced astigmatism (not present in every case)
Opportunity for clinicopathologic evaluation when the diagnosis is uncertain or when recurrent lesions raise concern for alternative diagnoses (biopsy practices vary by clinician and case)

This procedure is considered therapeutic (treating a problem), and in selected situations it can also support diagnosis when tissue is sent for pathology.

Indications (When ophthalmologists or optometrists use it)

Common scenarios where chalazion incision and curettage may be considered include:

A chalazion that persists despite a period of conservative management (timing varies by clinician and case)
A lesion large enough to distort the eyelid contour or cause noticeable asymmetry
Symptoms such as localized discomfort, heaviness, irritation, or tearing attributed to the lump
Visual fluctuation or blur suspected to be related to pressure on the cornea (more likely with larger lesions)
Recurrent chalazion in the same location, particularly if the appearance is atypical
Diagnostic uncertainty (for example, concern for a “masquerader” lesion), where tissue sampling may be appropriate
Multiple chalazia where targeted removal of the most symptomatic lesion is needed (overall approach varies by clinician and case)

Optometrists often identify and monitor chalazia and may co-manage care, while incision and curettage is typically performed by an ophthalmologist or an appropriately trained procedural clinician, depending on local scope-of-practice rules.

Contraindications / when it’s NOT ideal

chalazion incision and curettage may be less suitable, deferred, or modified in situations such as:

Primarily infectious eyelid disease (for example, an acute hordeolum/stye with active infection), where initial management may focus on infection control and inflammation (exact approach varies by clinician and case)
Diffuse eyelid or preseptal cellulitis or systemic illness, where broader medical management is often prioritized
Poorly defined diagnosis where a different workup is needed before proceeding, or where a biopsy-focused approach is preferred
Bleeding risk considerations, such as significant bleeding disorders or anticoagulant use, where peri-procedural planning may be required (varies by clinician and case)
Patient factors limiting cooperation (common in some pediatric cases), where sedation, an operating-room setting, or an alternative approach may be considered
Very small, minimally symptomatic lesions, where observation or less invasive options may be reasonable
Lesions near structures where scarring risk matters, such as near the eyelid margin or lacrimal drainage structures, where technique choice and risk discussion become more important

“Not ideal” does not always mean “never.” It often means that the clinician weighs risks, confirms the diagnosis, and considers other approaches that better match the presentation.

How it works (Mechanism / physiology)

A chalazion is typically a lipogranulomatous inflammatory lesion. In plain terms, this means oily material from a blocked gland leaks into surrounding tissue and triggers a localized inflammatory response. Over time, the lesion can become firm due to chronic inflammation and a surrounding capsule-like wall.

chalazion incision and curettage works by addressing the problem mechanically:

Incision creates an opening into the lesion, most often from the inner eyelid surface (the palpebral conjunctiva) to reduce visible scarring.
Curettage uses a small scraping instrument (a curette) to remove the thickened, inflammatory contents and break up loculated pockets.
Decompression and debulking reduce the inflammatory stimulus and allow the eyelid tissue to settle and remodel during healing.

Relevant anatomy (high level)

Meibomian glands: oil glands embedded in the tarsal plate that help form the tear film’s lipid layer.
Tarsal plate: dense connective tissue that gives the eyelid structure.
Palpebral conjunctiva: the smooth inner lining of the eyelid, commonly used as the approach site.
Eyelid margin: where lashes and gland openings are located; preserving margin integrity is important for eyelid function and tear film stability.

Onset, duration, and reversibility

Onset of effect: The lump may feel smaller immediately after the contents are removed, but visible improvement can continue over time as swelling resolves.
Duration: The goal is long-term resolution of that lesion, though recurrence can occur, particularly when underlying gland dysfunction persists.
Reversibility: This is not a reversible “device” or “medication effect.” Tissue contents are physically removed; healing and scarring patterns vary by clinician and case.

chalazion incision and curettage Procedure overview (How it’s applied)

Below is a general, non-step-by-step clinical workflow. Exact technique, setting, and instruments vary by clinician and case.

Evaluation / exam
– History (timing, prior episodes, associated eyelid disease such as blepharitis or rosacea, and any atypical features).
– Eyelid exam, sometimes with lid eversion to localize the lesion.
– Assessment for alternative diagnoses if the appearance is unusual or if lesions recur.
Preparation
– The procedure is commonly performed with local anesthesia in an office or ambulatory setting, though some patients may require a different setting.
– The eyelid is stabilized, often with a specialized clamp, to improve exposure and control bleeding.
Intervention
– A small incision is made into the chalazion, commonly from the inner eyelid surface.
– Curettage removes the contents and inflammatory material.
– Hemostasis (bleeding control) is checked.
Immediate checks
– The clinician checks the ocular surface and eyelid position, and confirms there is no concerning bleeding or injury.
– If tissue is collected for pathology, it is handled according to the clinic’s protocol (whether tissue is sent varies by clinician and case).
Follow-up
– Follow-up timing and instructions vary. The clinician reassesses healing, residual lump size, and any signs of recurrence or alternative diagnosis.

This overview is intended to explain the flow, not to guide self-management or decision-making for any individual case.

Types / variations

chalazion incision and curettage is a single named procedure, but clinicians may vary technique based on lesion location, recurrence, patient factors, and diagnostic concern.

Common variations include:

Transconjunctival approach (inner eyelid incision)
Often used because it avoids a skin incision and can reduce visible scarring.
Transcutaneous approach (skin-side incision)
Considered in selected cases, such as when the chalazion points externally or when inner access is less suitable. Scar visibility and lid anatomy influence the choice.
Incision and curettage alone vs combined approaches
Some clinicians combine mechanical removal with other measures (for example, addressing coexisting blepharitis or meibomian gland dysfunction).
In certain cases, an intralesional steroid injection is discussed as an alternative or adjunct (choice varies by clinician and case).
Primary therapeutic procedure vs biopsy-oriented procedure
When the lesion is atypical or recurrent, the procedure may be performed with a stronger emphasis on obtaining tissue for pathology to rule out other conditions.
Setting and anesthesia differences
Office-based local anesthesia is common.
Pediatric cases or patients unable to tolerate the procedure may require sedation or an operating-room environment (varies by clinician and case).

Pros and cons

Pros:

Can directly remove the obstructed inflammatory contents rather than waiting for gradual resolution
Often performed as a single-visit procedure in an outpatient setting (setting varies by clinician and case)
May relieve symptoms related to eyelid swelling, pressure, or cosmetic prominence
Can reduce corneal surface distortion from large lesions in some patients
Allows tissue sampling when there is diagnostic uncertainty (biopsy practices vary)
Typically limited to the eyelid, without systemic drug exposure

Cons:

Involves a procedure with local anesthesia and instrument use on the eyelid
Possible incomplete resolution or recurrence, especially when underlying gland dysfunction persists
Temporary swelling, bruising, or tenderness can occur after the procedure
Small risks of bleeding, infection, or irritation to the eye surface (risk profile varies by clinician and case)
Scarring is usually minimal with an inner-lid approach but is still a consideration, particularly with skin-side approaches
If the original diagnosis is incorrect, treating it as a chalazion may delay recognition of another condition

Aftercare & longevity

Outcomes after chalazion incision and curettage depend on factors related to the lesion, eyelid health, and follow-up. In general, clinicians monitor for resolution of the lump and for signs that the diagnosis or treatment plan needs reassessment.

Factors that can influence recovery and longer-term results include:

Size and chronicity of the chalazion: Long-standing lesions may have more fibrosis (scar-like tissue), which can affect how completely the lump resolves.
Underlying eyelid conditions: Blepharitis and meibomian gland dysfunction can contribute to repeated gland blockage. When these are present, recurrence risk may be higher.
Skin conditions and systemic associations: Rosacea and other inflammatory conditions can affect eyelid gland function in some individuals.
Technique and lesion location: The approach (inner-lid vs skin-side), how loculated the lesion is, and proximity to the lid margin can influence healing patterns.
Follow-up and reassessment: Persistent or recurrent lumps may prompt reconsideration of diagnosis and, in selected cases, pathology evaluation.
Ocular surface health: Dry eye disease and tear film instability can affect comfort during recovery and may coexist with the gland issues that contribute to chalazia.

“Longevity” in this context refers to whether the treated lesion stays resolved. While many lesions do not return after successful removal, new chalazia can occur if the underlying tendency toward gland blockage remains.

Alternatives / comparisons

Management of chalazion ranges from observation to procedures. The best comparison depends on lesion size, duration, symptoms, and diagnostic certainty.

Common alternatives include:

Observation / monitoring
Some chalazia slowly improve without procedural intervention.
This approach is often considered when symptoms are mild and the lesion is small, with continued reassessment if it persists.
Conservative eyelid care and inflammation control
Clinicians may recommend measures aimed at improving meibomian gland function and eyelid hygiene.
This can be used alone in early cases or alongside procedural care, depending on clinician preference and patient factors.
Medication-based approaches (selected cases)
When there is associated inflammation of the lid margin or concern for secondary infection, medication may be considered.
Antibiotics do not treat a non-infectious chalazion itself, but may be used when overlapping conditions are present (choice varies by clinician and case).
Intralesional steroid injection
A steroid injection into the lesion may reduce inflammation and size in some cases.
Compared with chalazion incision and curettage, it avoids scraping removal but may require more than one treatment and has its own risk considerations (for example, skin pigment change or local tissue effects; risks vary by clinician and case).
Biopsy or excision for atypical/recurrent lesions
When the appearance is not typical, or lesions recur in the same place, clinicians may prioritize tissue diagnosis to rule out other eyelid tumors or inflammatory conditions.

High-level comparison: chalazion incision and curettage is a direct, mechanical treatment that removes lesion contents; steroid injection is anti-inflammatory and may shrink the lesion without opening it; observation/conservative care focuses on time and gland health; biopsy-oriented approaches emphasize diagnostic certainty.

chalazion incision and curettage Common questions (FAQ)

Q: Is chalazion incision and curettage the same as treating a stye?
A: Not exactly. A stye (often called a hordeolum) is typically an acute infection of an eyelid gland, while a chalazion is usually a non-infectious inflammatory lump from gland blockage. A chalazion can sometimes develop after an acute stye improves.

Q: Does the procedure hurt?
A: The eyelid is usually numbed with local anesthesia, so pain during the procedure is often limited, though pressure sensations can still be noticeable. Afterward, soreness or tenderness can occur as the lid heals. Individual experience varies by clinician and case.

Q: How long does it take to recover?
A: Many people have temporary swelling or bruising that improves over time, with gradual smoothing of the eyelid contour. The timeline varies depending on lesion size, chronicity, and individual healing. Clinicians typically plan a follow-up to confirm resolution.

Q: Will the chalazion come back after incision and curettage?
A: The treated lesion may resolve and not return, but recurrence is possible. New chalazia can also develop if underlying meibomian gland dysfunction or eyelid inflammation persists. Recurrence risk varies by clinician and case.

Q: Is it considered safe?
A: It is a commonly performed eyelid procedure, but any procedure has risks. Potential issues include bleeding, infection, irritation to the eye surface, scarring, or incomplete resolution. The overall risk profile depends on patient factors, lesion location, and technique.

Q: Will I be able to drive afterward?
A: Driving depends on comfort, vision clarity, and whether any temporary blurring occurs from ointment, tearing, or swelling. Some clinics recommend arranging transportation, especially if vision may be temporarily affected. Policies and expectations vary by clinician and case.

Q: Can I use screens or read after the procedure?
A: Screen use is usually limited more by comfort than by a strict restriction. Tearing, light sensitivity, or irritation can affect how soon reading and screens feel comfortable. Clinicians may provide individualized guidance based on how the eye surface looks after the procedure.

Q: What does it cost?
A: Costs vary widely by region, clinic setting (office vs surgery center), insurance coverage, and whether pathology testing is performed. Fees may include the procedure itself, facility costs, medications, and follow-up visits. For an accurate estimate, clinics typically provide a pre-procedure quote or insurance check.

Q: Will I need antibiotics or eye drops afterward?
A: Some clinicians prescribe topical medications after the procedure, while others may not, depending on findings and risk factors. If a coexisting eyelid condition is present, treatment may focus on that as well. The plan varies by clinician and case.

Q: When is a biopsy considered?
A: Biopsy is more likely when a lesion is recurrent in the same location, has atypical features (unusual color, ulceration, lash loss, abnormal blood vessels), or does not behave like a typical chalazion. In such cases, tissue testing helps rule out other eyelid conditions. Whether biopsy is done routinely or selectively varies by clinician and case.